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Abstract
Bioactive lipids serve as intracellular and extracellular mediators in cell signaling in normal and
pathological conditions. Here we describe that an important regulator of some of these lipids, the
lipid phosphate phosphatase-3 (LPP3), is abundantly expressed in specific plasma membrane
domains of Bergmann glia (BG), a specialized type of astrocyte with key roles in cerebellum
development and physiology. Mice selectively lacking expression of LPP3/Ppap2b in the nervous
system are viable and fertile but exhibit defects in postnatal cerebellum development and
modifications in the cytoarchitecture and arrangement of BG with a mild non-progressive motor
coordination defect. Lipid and gene profiling studies in combination with pharmacological
treatments suggest that most of these effects are associated with alterations in sphingosine-1-
phosphate (S1P) metabolism and signaling. Altogether our data indicate that LPP3 participates in
several aspects of neuron-glia communication required for proper cerebellum development.
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INTRODUCTION
Lysophospholipids (LPs) such as lysophosphatic acid (LPA) and S1P play important roles in
central nervous system (CNS) development, physiology and disease. The biosynthetic
machinery and receptors responsible for LPs production and signaling are broadly
distributed in the embryonic and adult brain with strong expression in neurogenic areas. In
vitro studies have shown that LPA and S1P alter several cellular responses in neurons and
glia (Brindley and Bräuer 2009; Milstien et al. 2007). Both have potent neurite retracting
activity in postmitotic neurons and neuronal cell lines, through the activation of Rho
signaling (Fukushima et al. 2002; Postma et al. 1996; Sato et al. 1997) and serve as
regulators of neuroblast morphology and migration (Fukushima et al. 2000; Kimura et al.
2007). Additionally, LPA and S1P modulate intracellular Ca2+ in neurons and glia (Giussani
et al. 2007; Holtsberg et al. 1997), promote astrocytic proliferation (Bassi et al. 2006; Shano
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et al. 2008) and modulate neuronal excitability (Sim-Selley et al. 2009; Trimbuch et al.
2009).
In ex vivo experiments, activation of LPA receptors induces folding and widening of the
embryonic cerebral cortex, due to decreased cell death and increased terminal mitosis
(Kingsbury et al. 2003). In contrast, a sub-line of Lpar1 knockout mice, shows abnormal
cortical development and increased cell death (Estivill-Torrus et al. 2008). Mice lacking
receptor S1P1 show increased cell death and reduced proliferation in the forebrain and die
past mid-gestation due to defective vascular maturation (Mizugishi et al. 2005). The targeted
inactivation of S1pr2 yielded viable animals with no apparent anatomical or physiological
defects, although they show sporadic seizures and increased excitability of neocortical
pyramidal neurons (MacLennan et al. 2001). These observations show that LPA- and S1P-
receptor mediated signaling play fundamental roles in CNS development and in modulating
neuron excitability. In addition, abnormal S1P and LPA signaling participate in the etiology
of several neuropathological conditions (Dennis et al. 2005; Nixon 2009).
Determining the specific in vivo function of these LPs has been precluded in part due to the
elevated number of existing receptors and the apparent redundancy between them. However,
studies of the enzymes that synthesize or metabolize these lipids strongly supports their role
in development, normal physiology and disease. That is the case of autotaxin (Dennis et al.
2005; van Meeteren et al. 2006), sphingosine kinases (Mizugishi et al. 2005), sphingosine-1-
phosphate lyase (Fyrst and Saba 2008), lipid phosphate phosphatases (LPPs) (Escalante-
Alcalde et al. 2003) and LPP-related proteins (Trimbuch et al. 2009).
LPPs are a family of integral membrane enzymes with a wide spectrum lipid phosphate
phosphohydrolase activity. Mammalian LPPs hydrolyze phosphatidic acid and ceramide-1-P
besides LPA and S1P, originating diacylglycerol, ceramide, monoacylglycerol and
sphingosine, respectively (Brindley et al. 2009). For this reason LPPs are considered
regulators of the biological responses mediated by these lipids. Among the three LPPs
described in mice, LPP3/Ppap2b is the only one which is essential for embryo development
(Escalante-Alcalde et al. 2003), suggesting particular and non-redundant functions for this
enzyme.
The role of LPPs in the development and function of the CNS has not been explored. In this
paper we show that neural deficiency of LPP3 produces a mild motor coordination defect
and abnormalities in cerebellar foliation, the latter related to alterations in the morphology,
distribution and density of BG cells during cerebellum development. Remarkably, lack of
LPP3 also leads to increased S1P concentration and down-regulation of S1P1 receptor in the
cerebellum indicating that this enzyme is a key modulator of S1P signaling in this region.
Pharmacological treatment with a S1P1 functional antagonist partially mimics the alterations
found in BG strongly suggesting that the observed cerebellar alterations are associated to
abnormal S1P/S1P1 metabolism and signaling.
MATERIALS AND METHODS
Mouse strains and generation of neural-specific LPP3-knockout mice
For gene expression analysis, the Ppap2btm2Stw allele (Ppap2blacZ), expressing β-
galactosidase (β-gal) as a reporter was used (Escalante-Alcalde et al. 2009). For neural
inactivation of LPP3, homozygous or heterozygous conditional Ppap2btm3Stw (Ppap2bflox)
females were crossed with Tg(Nes-cre)1Kln; Ppap2btm3Stw/+ or Ppap2btm3Stw/tm3Stw males
and their progeny were genotyped by PCR from genomic DNA of neural and non-neural
tissues as previously described (Escalante-Alcalde et al. 2007).
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Gross motor coordination defects were assessed on a Rotarod using two fixed rotation
speeds in 1 month-old animals. After two training sessions, animals were placed on the
Rotarod for 240 seconds, or until they fell off (latency to fall). Regardless of completion or
fall, each animal was allowed to rest for 2 minutes between each trial. Each testing session
consisted of 10 trials. Animals were tested at 20 rpm and 30 rpm on consecutive days and
data expressed as the mean ± s.e.m. To assay for fine motor coordination defects, animals of
one month of age were subjected to the beam-walking test. Performance was determined by
measuring the time (up to 240 seconds) that mice were able to stay on round beams of two
different diameters (5 and 7 mm). Another parameter evaluated was their behavior while
walking on the beam. These tests were repeated in one year-old animals.
Immunohistochemistry, immunofluorescence, TUNEL and confocal microscopy
Perfused brains were fixed ON in 4% paraformaldehyde and 30 µm sagittal slices were
obtained in a vibratome (Leica Microsystems). Floating sections were permeabilized and
blocked with 1% Blocking Reagent (Roche) in PBS-Tween 0.3% for 2 hours. Antibodies
(Abs) were diluted in blocking solution and incubated ON at 4°C: Rabbit anti-LPP3 (1:200),
rabbit anti-Calbindin (1:100, Millipore), mouse anti-Parvalbumin (1:1000, Sigma), rabbit
anti-BLBP (1:200), rabbit anti-GFAP (1:1000), rabbit anti-pHistone-H3 (1:100, Cell
Signaling). For some Abs, sections were mounted on slides and treated with Antigen
Unmasking Solution (Vector) followed by immunoperoxidase/nickel (Vectastain kit,
Vector) or immunofluorescence: mouse anti-PCNA (1:100, Vector); guinea pig anti-Glast
(1:1000); rabbit anti-p27 (1:100, Santa Cruz); mouse anti-S100B (1:100, Millipore); rabbit
anti-EDG1 (1:100). Appropriate secondary Abs coupled to Alexa-488, Alexa-594
(Invitrogen), Texas Red or Cy5 (Jackson) were used for double and triple
immunofluorescence. For TUNEL, sections were mounted and treated following provider’s
instructions (Boheringer, Germany). Sections were examined under a FV1000 confocal
microscope (Olympus). Dual- or triple-color images were acquired using sequential
acquisition to avoid cross-excitation. For co-localization experiments or high-resolution
data, images were acquired with confocal aperture between 80–100 nm.
Cell counting
Confocal images acquired with equivalent conditions and in corresponding cerebellar
regions were analyzed in sagittal sections at the mid vermis. Purkinje (PC) and BG cell
somas found in the area corresponding to 300 µm of Purkinje cell layer (PCL) (defined as
area unit) were counted. Identification of PC and BG was by parvalbumin or calbindin and
BLBP immunoreactivity, respectively. For interneurons and ectopic BG cell somas in the
molecular layer (ML), parvalbumin- and BLBP-positive cell somas were counted in the area
of ML between 300 µm of PCL and the pia (defined as area unit). Phospho-Histone-H3 and
TUNEL positive cells found in the external granule layer (EGL), PCL and ML (if present)
were counted per lobe or folia taking as boundaries the deepest part of the sulcus between
folias. The total number of positive cells/layer/cerebellum was counted. Number of positive
cells in conditional neural specific knockouts, were expressed as the percentage of control
littermates (100%).
Quantification of glycero- and sphingo-phospholipids by high-pressure liquid
chromatography and tandem mass spectrometry (LC-MS /MS)
Lipids from perfused cerebellar tissue (around 20 mg wet weight) were extracted using
acidified organic solvents with 50 pmol C17 LPA added as a recovery standard. Samples
were evaporated to dryness, and redissolved in 4:1 MeOH; CHCl3 for determination of
phospholipid phosphorous and analysis by HPLC electrospray ionization tandem mass
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spectrometry using selective reaction monitoring mode assays and methods that have been
described in detail elsewhere to measure PA, LPA and S1P (Albers et al. 2010; Mathews et
al. 2010; Miriyala et al. 2010; Su et al. 2009). Data were corrected for recovery of the C17
LPA internal standard and lipid species were quantitated by reference to calibration curves
generated using synthetic standards (Avanti Polar Lipids) that were independently
quantitated by lipid phosphorous determination. The data shown are means of triplicate
measurements made with independent samples.
Pharmacological treatment with FTY720 in vitro and in vivo
For cerebellar organotypic slice cultures, anesthetized wildtype (ICR strain) or genetically
modified mice at P7 were perfused with artificial cerebral spinal fluid, the cerebellum
aseptically removed and cut into 300 µm sagittal sections. Slices were then transferred to
Millicell CM culture inserts (Millipore) in 35 mm culture dishes containing 1 ml of medium
(DMEM-F12 50%, horse serum 25%, HBSS 25%, glutamine 1 mM, KCl 25 mM, glucose 6
mg/ml, and antibiotics) and maintained for 48 hrs at 37° and 5% CO2. Treatments (vehicle
or FTY720 100 nM, Caiman Chemical) were added at the start of the culture. Slices were
fixed ON with methanol-DMSO (4:1) and stained in whole mount against BLBP by
immunofluorescence. Each experimental group was visualized using the same optical
parameters under the confocal microscope. For in vivo treatments, FTY720 (0.3 µg/g of
body weight) or vehicle was administered by intraperitoneal injection (i.p.) to mice from P3
to P14 and immunofluorescence or immunohistochemistry was performed as described
earlier.
RESULTS
LPP3 is highly abundant in specific plasma membrane domains of Bergmann glia cells
LPP3 expression was initially analyzed in whole brain using a previously described Ppap2b-
reporter allele (Escalante-Alcalde et al. 2009). In adult mice, β-gal was most strongly
detected in the cerebellar cortex, followed by the olfactory bulb, the rostral migratory stream
and the ventricular system. A less conspicuous expression was found in the hypothalamus
(Fig. 1A). Within the cerebellum, β-gal was restricted to the ML and PCL (Fig. 1B), being
the somata of the BG the region with strongest reporter activity. Mature BG cells are
unipolar astrocytes located around the somas of PC (around 8 BG/per PC). Each BG cell
gives rise to several intermediate filament-rich radial processes that traverse the ML and end
at the pial surface. Each radial process is decorated with small secondary processes and a
complex system of small lateral appendages rich in neurotransmitter transporters (i.e. Glast),
which are in close interaction with synapses (Grosche et al. 2002; Yamada and Watanabe
2002) participating in removal of neurotransmitters released during synaptic activity
(Bordey and Sontheimer 2003; Huang and Bordey 2004). During postnatal cerebellum
development BG cells participate in the radial migration of external granule cells (EGC) as
they use BG radial processes as guidelines to reach the internal granule layer (IGL) (Rakic
1971) and assist the morphogenesis of the PC dendritic tree (Yamada et al. 2000).
Furthermore, it has been recently described that adult BG cells exhibit stem-cell like
properties (Alcock and Sottile 2009).
The expression pattern revealed with our Ppap2b reporter allele resembles the mRNA
expression pattern of the rat homolog (Suzuki et al. 1999) however no studies describing
LPP3 protein distribution in BG cells exist. To examine the subcellular localization of LPP3
in adult BG cells we performed double or triple immunofluorescence using Abs against
LPP3 and for markers of BG (Glast, S100B) and PC/interneurons (Parvalbumin) (Fig. 1C–
Q). LPP3 was expressed in the entire ML, with a similar pattern to that of Glast (Fig. 1C–F,
I–K), which is expressed in the plasma membrane-domains of BG that ensheath the dentritic
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tree of PC (Yamada et al. 2000). Confocal analysis showed that LPP3 co-localized with
Glast but was absent in PC and interneurons (Fig. 1G, H, O). Furthermore, LPP3 expression
in BG cells also co-localized with S100B-positive lateral branches but was absent on radial
processes (Fig. 1L–N), except for some near the pial surface (Fig. 1P). These results show
that LPP3 in BG cells is restricted to the plasma membrane domains that ensheath the PC
dendritic trees and synapses, and suggest that it participates in some aspects of the neuron-
glia communication in the adult cerebellar cortex.
BG precursors are generated in the ventricular zone (VZ) of the cerebellar primordium
around embryonic day 13 (E13) (Miyake et al. 1995) and migrate towards the cortex due to
shortening of their radial processes adhered to the pial surface through their end feet (Yuasa
1996). Around the perinatal stage, the Glast-positive somas of BG organize into the PCL in
a rostral-caudal fashion, while their radial processes cross the EGL and their end feet form
the glia limitans at the pial surface (Yamada et al. 2000). BG shafts provide scaffolding
during external granule cell radial migration, while the development of their fine lateral
reticular processes accompanies the ensheathment of the developing dendritic tree of PC
during the second postnatal week (Yamada et al. 2000).
To analyze LPP3 expression during BG and cerebellum development, we used a reporter
allele, immunohistochemistry and immunofluorescence in cerebella from E16 to postnatal
day 10 (P10) individuals (Fig. 2). At E16, expression of LPP3 was restricted to two
domains, at the most mid-rostral region and at the ventricular and intermediate zones (Fig.
2A asterisks); this expression pattern is in agreement with the ventricular origin of BG
precursors. Around the perinatal period, a strong LPP3 expression domain was observed in
the junction between the rostral-most part of the cerebellum primordium and the developing
velum medullaris (Fig. 2B–C). Furthermore, LPP3-positive cells in the PCL became initially
evident in the rostral lobules and forming posterior fissures. Appearance of LPP3-positive
cells with radial processes that traverse the EGL correlated with the degree of alignment of
BG into the PCL at this stage (Yamada et al. 2000), supporting its identity as BG. In
addition, a weak LPP3-expressing domain was observed in the anterior medulla of early
postnatal cerebella (Fig. 2B inset), which extended to the entire medulla by P4 (Fig. 2D
inset). At P4, LPP3-expressing BG cells arranged along the entire PCL (Fig. 2D) while the
positive cells found in the medulla disappeared as development progressed, in agreement
with disappearance of immature BG from this area. By P10, LPP3 expression was
essentially identical to the adult stage except for the presence of LPP3-positive radial
processes that still cross the remaining EGL (Fig. 2E–F). The developmental expression
pattern of LPP3 described indicate that this enzyme is weakly expressed in BG precursors
(E16), becomes highly expressed in immature and mature BG cells (perinatal stage onwards)
and reflects the dynamic transformation that this cell type undergoes during postnatal
development.
Lack of LPP3 alters S1P metabolism and S1P1 expression in the cerebellum
Due to the early embryonic lethality of Ppap2b null mutants we used a genetic approach to
conditionally inactivate Ppap2b in neural precursors. The Ppap2btm3Stw conditional allele (f)
(Escalante-Alcalde et al. 2007) and a Nestin::Cre transgenic (Tronche et al. 1999) were used
to inactivate the gene in neuron-glial progenitors from around E11 onwards (stage at which
the transgenic broadly expresses Cre in nervous system). Nestin::Cre-mediated neural
inactivation of Ppap2b resulted in viable and fertile mice, indicating that neuron-glial
expression of LPP3 after E11 is not essential, however mice were ~20% smaller than
controls. The highly efficient recombination of Ppap2b locus in the cerebellum of adult
Nestin::Cre; Ppap2btm3Stw/tm3Stw animals (from here onwards referred as CKO in the text
and Ppap2bNΔflox/NΔflox or simply Δf/Δf in the figures) was corroborated by PCR of
genomic DNA (data not shown), western blot and immunofluorescence (Fig. 3A). Out of the
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three LPPs found in mice, LPP3 is the only abundantly expressed in the adult cerebellum
(Fig. S1), thus inactivation of Ppap2b should render changes in concentrations of their
lipidic substrates and/or products. We performed lipid profiling by LC-MS/MS in CKO as in
control cerebella and found that the level of S1P was consistently elevated in cerebellar
tissue samples from CKO mice in comparison to controls, while LPA and PA or LPC (the
latter not an LPP substrate) showed no statistical differences (Figs. 3B, S2A). Aside from
our previous observations showing that LPA, PA and DAG levels are modified in null LPP3
mouse embryo fibroblasts in vitro (Escalante-Alcalde et al. 2003), the physiological role of
LPP3 in lipid phosphate metabolism in vivo was largely unexplored. Our results indicate
that LPP3 is a functional S1P phosphatase in the mouse cerebellum and is required for
maintaining the appropriate levels of this lipid in that structure.
The presence and role of S1P in the cerebellum has been slightly studied: Sphingosine
kinase (SPHK) activity in the CNS is highest in the cerebellum (Blondeau et al. 2007),
SPHK1 expression has been found compartmentalized in some PC parasagittal stripes
(Terada et al. 2004) and S1P can also be synthesized by cerebellar astrocytes and granule
cells (Anelli et al. 2005). Furthermore, S1P promotes the proliferation of cerebellar
astrocytes (Bassi et al. 2006) and produces Ca2+ signaling in cerebellar astrocytes and
differentiated granule cells (Giussani et al. 2007). Between the mRNAs coding for S1P
receptors expressed in the adult mouse cerebellum, the most abundant in the PCL and in the
entire cerebellum is for the receptor 1 (S1P1/S1pr1, Fig. S1). In addition, transcripts coding
for proteins involved in S1P signaling (S1P1 and SPHK2) have been found highly enriched
in mouse BG cells at P30 (Koirala and Corfas 2010) suggesting that BG cells are a major
contributor to S1P signaling in the cerebellum. To date no information exists regarding the
abundance and distribution of S1P1 in the mouse cerbellum, thus we performed S1P1
immunofluorescence and immunohistochemistry. In control cerebella S1P1 was primordially
detected in the ML with a pattern similar to that of LPP3 and Glast implicating that its
expression is mainly in BG; however due to the origin of the antibodies we were only able to
show co-localization between S1P1 and Glast (Figs. 3C and S2C). This result indirectly
shows that S1P1 and LPP3 are at least located in the same plasma membrane domains of BG
cells. Surprisingly, when we analyzed the expression of S1P1 in CKO cerebella, a
pronounced decrease in the amount of S1P1 in the ML was observed in the adult as well as
in the developing postnatal cerebellum (Fig. 3C and S2D–G). To rule out a possible artifact
of the antibody staining we performed western blot, which confirmed our immunostaining
results (Fig. 3D) and pointed to a down-regulation of the receptor in the mutant cerebellum.
The amount of S1pr1 mRNA was unaltered in the CKO, which suggested that the decrease
in the amount of receptor is due to degradation (Fig. S2B). Given the dramatic decrease in
the amount of S1P1, we explored whether the CKO adult cerebellum, showed global
changes in the activation of some S1P1 downstream signaling molecules. While AKT
activation was diminished in CKO cerebellum extracts vs. controls, activation of ERK1/2
was increased. On the other hand, we were unable to detect consistent differences in the
activation of PKC (Fig. S2H). Altogether these data suggest that a sustained activation of
S1P1, due to the increase in extracellular S1P availability, is responsible for the
internalization and degradation of this receptor in CKO animals, even during early postnatal
cerebellum development. Experiments in isolated BG cells will be required to further dissect
the signaling consequences of the absence of LPP3 in this system, however our results
clearly demonstrate the requirement of LPP3 expressed in BG for the regulation of S1P
metabolism/signaling in the cerebellum in vivo.
Neural inactivation of Ppap2b produces mild defects in motor coordination
The cerebellum is the structure that regulates learning and coordination of skilled
movements. Thus we subjected control and CKO animals to neurological tests to reveal
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motor dysfunctions. On the Rotarod, which measures coarse motor performance, one month-
old CKO mice showed significant smaller latency periods to fall at 20 and 30 rpm (Fig. 4A).
On the fixed bar test, which reveals fine motor coordination defects particularly of the
hindlimbs, performance of CKO mice was considerably affected in 100% of individuals.
Although they were able to stay and move along the beam, they showed grasping and
pulling movements with the forepaws and dragged the hindlimbs on the beam (Fig. 4B). No
signs of worsening were found in one year-old mice, indicating that the motor dysfunction
was not progressive at least up to this age. These results suggested possible alterations in the
cerebellum physiology.
LPP3 deficiency in the cerebellum produces foliation defects and alters BG arrangement
and cytoarchitecture
One source of altered cerebellar function corresponds to malformations with developmental
origin (Chizhikov and Millen 2003). Since BG plays fundamental roles in cerebellum
development we analyzed the structure of control and CKO adult cerebella and found
alterations in the foliation pattern of mutants (Fig 5, S3). Macroscopic analysis showed a
pronounced hypotrophy of folias IV–V (Fig. S3) and IX (data not shown). Histological
analysis of sagittal sections at the mid vermis from CKO cerebella revealed: i) hypoplasia of
folia III; ii) a less pronounced precentral fissure; iii) reduced folia IV–V (culmen); iv)
reduced or absent intercrural fissure in folia VI/VII and v) underdeveloped folia IX (uvula)
with absent uvular sulcus (Fig. 5 A, E). Also, in the most rostral area of the vermis, near the
junction to the velum medullaris, a lingular-like sulcus with an abnormal accumulation of
cells in the dorsal side of the molecular layer was observed (Fig. 5E).
To further study whether LPP3 deficiency affected the cytoarchitecture of BG or other
cerebellar cell type in the adult stage, we analyzed PC, interneuron and BG arrangement,
density and morphology at this stage. Morphology and density of PC in CKO were not
evidently affected (Fig. 5B, F and I), however a mild disorganization of PC somas was
sometimes observed in earlier stages (Fig. 6C–D). The number and distribution of
interneurons along the ML were neither affected (Fig. 5B, F and I). In contrast, BG
numbers, arrangement and morphology were evidently altered in CKO adult animals (Fig.
5C–D, G–I). While in control cerebella the radial processes of BG had the typical palisade
distribution, with their end feet at the pial surface and their somas located at the PCL, in the
CKO the radial processes looked thicker and disorganized, and many of them did not reach
the pial surface. Furthermore, their somas looked less organized within the PCL and were
frequently misplaced in the ML. BG was 41.6% less abundant in the CKO PCL than in
controls and 11% of total BG cells were located in the ML of CKO animals. These
abnormalities were found along the ML regardless of the folia observed. Confocal analysis
revealed an apparent increase in the intensity of GFAP so we performed western blot of
cerebellum protein extracts using antibodies against GFAP and two other BG markers,
BLBP and Glast. Remarkably, while Glast showed no difference, BLBP and GFAP were
increased 2- and 1.5-fold respectively, in CKO extracts versus controls (Fig. S4). The exact
meaning of this result remains to be established, however it is worth noting that up-
regulation of GFAP is considered a landmark of reactive gliosis, which is normally
associated with neural damage.
To address how early BG is affected in the CKO, we analyzed its positioning and
morphology during postnatal cerebellum development. We found an abnormal arrangement
of BG somas in the developing PCL as early as P4 (Fig. 6A–B), while ectopic BG somas in
the ML were evident at P10–15 (Fig. 6C–D). At the latter stages, besides the disarrangement
of BG somas, their radial processes were already thicker, tortuous and many of them did not
reach the pial surface. Furthermore the complexity of their fine lateral processes was
apparently reduced. In addition, a decrease in the density of BLBP-positive somas in the
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PCL was apparent in these early stages (Fig. 6A–D), suggesting a decrease in BG numbers
even during early postnatal stages.
Rostral-most defects are associated to alterations in LPP3-expressing glial cells
As mentioned earlier, an abnormal accumulation of cells was observed in the dorsal side of
the molecular layer in the most rostral area of the vermis (Fig. 5E). The composition of this
cumulus of cells was heterogeneous and formed by interneurons, PC, proliferating and
postmitotic granular cells, astrocytes and BG cells (Fig. S5 A–E). In E17.5 mouse embryos,
the medial cerebellum is delimited at the rostral end by the extension of the EGL, which
ends almost at the isthmus in the mid-hindbrain boundary (MHB). During the next few days,
an isthmic-derived structure develops and forms a wide sheet of cells devoid of neurons, the
velum medullaris (VM). This structure links the anterior vermis to the inferior culliculus. To
gain further insight into the origin of this rostral abnormality we analyzed mid-rostral
cerebellum development in P0–P1 individuals. Sections at the mid vermis region were
analyzed to observe the extension of EGC rostral migration, the location of PC and the
structure of the VM. As shown in figure S5 (F–G), in P0 CKO cerebellum the EGL
extended rostrally up to the VM and was mildly curved. Moreover, the morphology of
BLBP-positive radial glia, including BG cells, was altered: in the cerebellar area, radial
processes that crossed the EGL were enlarged while in the velum area showed signs of
disorganization, leading to an apparent disruption of the glia limitans. At P1 (Fig. S5 H–I)
the curvature of the EGL was more pronounced even folding the most anterior end of this
layer. Remarkably, a cumulus of calbindin-positive cells, presumably PC, was already
observed in the dorsal side of this sulcus-like structure. Two possible cellular mechanisms
could account for the formation of this abnormal structure, a localized increase in the
proliferation rate of EGC or defective elongation of the velum medullaris. We found no
evidence of increased proliferation rate of EGC in this area (Fig. 7C) suggesting that the
sulcus-like structure arises due to defective elongation of the VM. Altogether these data
suggest that in the perinatal cerebella, LPP3-expressing cells (presumably radial glia) in the
velum and in the junction between the velum and the anterobasal lobe of the vermis (white
arrowheads in Fig. 2B–C) play a fundamental role in controlling the elongation of the velum
and proper formation of the glia limitans in this area.
Deficiency of LPP3 in BG produces proliferation defects and EGC delayed migration
As noted, adult CKO cerebellum showed hypoplasia and reduction or disappearance of
fissures and sulci. These phenotypes are frequently associated to defects in migration,
proliferation and/or survival of granule cells (Chizhikov and Millen 2003). In the mouse,
EGC use the radial processes of BG cells as scaffolds to reach the IGL from around the
perinatal stage onwards being the peak of migration between P8 and P10 (Yacubova and
Komuro 2002). Since LPP3-deficient BG cells showed morphological defects from early
stages of cerebellum development, it was possible that EGC had secondary developmental
abnormalities associated to this phenotype (Rakic and Sidman 1973). We found that in CKO
cerebella, between P10–P15, the EGL was thicker than in control littermates (Figs. 6C–D,
7A–D); however in adult animals no sign of remaining EGC was detected (Fig. 5A, E). This
observation suggested a delayed migration of EGC in the CKO. To test this possiblility, we
analyzed the amount and distribution of PCNA- and p27-positive cells (proliferating and
postmitotic premigratory EGC, respectively) in P15 cerebella. In regions where a few
PCNA-positive cells were observed in fissures of control cerebella, the corresponding areas
in CKO showed a large amount of PCNA positive cells (Fig. 7A–B). Furthermore, in areas
where proliferating EGC were still found in controls (i.e. folias VI–VII and X), the thickness
of the EGL positive to PCNA was larger in CKO (not shown). Similar observations were
found in regard to the thickness of EGL with postmitotic cells (p27-positive) in the CKO
animals vs. controls (Fig. 7C–D). Indication of delayed migration of EGC was strongly
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suggested by the reduction of p27-positive fusiform cells found in the molecular layer of
CKO cerebella compared to control animals (arrowheads in Fig. 7C–D).
Delayed granule cell migration on its own might not account for the hypoplastic/foliation
phenotypes found in mutants suggesting additional alterations in proliferation and/or cell
death rates during CKO cerebellum development. To test this hypothesis, we performed a
time-course analysis of proliferation (phospho-Histone-H3) and cell death (TUNEL) in
CKO vs. control cerebella between P0–P15. Remarkably, a decrease in mitotic cells and an
increase in TUNEL-positive cells were observed in CKO cerebella in a temporal and
regional fashion (Fig. 7E–H). At P0–1, proliferating cells in the EGL were not altered while
in the PCL a decrease in mitotic cells (18%) was observed in CKO. By P4 (estimated to be
near the proliferation peak of BG cells in the mouse, Shiga et al, 1983) a significant decrease
(33%) in the number of mitotic cells was observed in the EGL (principally in folias of the
anterior lobe) and in the PCL (28%; principally in folias IV–VIII). Between P0–P4, most of
the cells that proliferate in the PCL are BG, implying that this cell type is the one affected by
the absence LPP3 in this layer. At P7–8, no differences in proliferation were found in the
PCL (BG already cease proliferation at the stages), but a 17% reduction in proliferating cells
in the EGL was observed principally in folias III and X. Finally, a considerable increase (2.6
fold) in TUNEL-positive cells was detected in the EGL and ML of CKO cerebella at P15.
This correlated with the delayed EGC migration observed at this stage, suggesting that the
ectopically differentiated GCs that do not reach the internal granule layer die. Thus foliation
defects seem originated by a combination of reduced proliferation, increased cell death and
delayed migration of EGC, all secondary to BG defects.
In vitro and in vivo treatments with a S1P1 functional antagonist, partially phenocopies
developmental cerebellum alterations
We finally explored if S1P/S1P1-signaling alterations could contribute to the developmental
defects observed. FTY720 is a S1P receptor modulator, which is phosphorylated by
sphingosine kinases in vivo to form the active compound FTY720-P. The latter causes
internalization and degradation of S1P1 expressed at the plasma membrane, thereby working
as a S1P1 functional antagonist (Brinkmann 2009; Nixon 2009). Due to its lipophilic nature
FTY720 crosses the blood-brain barrier (Foster et al. 2007) and recent evidence suggests
that it can act in CNS cells including astrocytes (Miron et al. 2008). Taking advantage of the
properties and mechanism of action of this drug on S1P1, we performed slice organotypic
cultures of P7 wildtype cerebella incubated for 48 hrs in the presence or absence of 100 nM
FTY720 and then BG morphology was analyzed by immunofluorescence against BLBP. As
shown in figure 8, FTY720 treatment produced alterations in BG morphology, including
thickening of radial processes and a mild reduction in the complexity of the fine lateral
processes, although the morphological changes were not as severe as those found in cultured
LPP3 deficient cerebella (Fig. 8A–D). To obtain a chronic effect of the drug through
cerebellum development we then treated pups between P3–P14 with FTY720 at a dose used
to treat a mouse model of multiple sclerosis (Foster et al. 2009) (0.3 µg/g of body weight,
daily i.p. injection) and then assessed BG morphology and arrangement, S1P1 expression
and EGC proliferation. In FTY720 treated-animals (n=4), BG radial processes were thicker
than in controls along the entire ML while BG soma arrangement was just regionally
perturbed (Fig. 8E, F). In folia X, which is one late-developing folia, BG somas were not
homogeneously aligned within the PCL. In addition some ectopic somas were found within
the ML of this folia and with less frequency in other folias. BG ectopia was never observed
with the same frequency in animals treated with vehicle (n=3) (Fig. 8E, F). The low
expressiveness of phenotypes observed could be due to the relatively low dose of drug used
and/or the short and late window of time (in terms of cerebellum development) in which the
treatment was applied. We indirectly analyzed the effectiveness of FTY720 treatment
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through the detection of S1P1 expression in control and treated cerebellum sections by
confocal microscopy under the same optical parameters. S1P1 expression was reduced by
FTY720 treatment although not to the extent found in CKO cerebella (compare Figs. 3C, D
and 8G, H). Furthermore, the regions where a more prominent decrease in S1P1 expression
was observed correlated with folia showing more pronounced alterations. Finally, the
thickness of EGL positive to PCNA in the intercrural fissure of treated animals was
increased (27%) as occurred in the CKO (Fig. 8I, J), although in a more moderate fashion.
Altogether these results strongly suggest that alteration in S1P metabolism/signaling, due to
the lack of LPP3 activity in BG cells, contribute to the developmental abnormalities found.
DISCUSSION
Although it has been recently reported an important role for an LPP-related protein, PRG1/
LPPR4, in hippocampal excitability (Trimbuch et al. 2009) no information regarding the
participation of bona fide LPPs in the function and development of the CNS exists.
Abundant Ppap2b transcription has been found in neurogenic areas of the rat brain (Suzuki
et al. 1999), however the exact identity of the cells that express LPP3 in these regions
remains unidentified. Transcriptional profiling studies in human brain showed that Ppap2b is
within the top ten genes with highest membership to a group enriched in markers of
astrocytes, which in turn have a significant overlap to a group rich in neurogenic markers
(Oldham et al. 2008), suggesting that LPP3 is abundantly expressed in a population of
astrocytes involved in neurogenic processes. Supporting this notion we found that in
developing and adult cerebellum, LPP3 is restricted to BG astrocytes and its precursors, with
a highly strong expression found in immature and mature BG (from P0 onwards), which
have been found to possess stem cell-like properties (Alcock and Sottile 2009).
The subcellular distribution of LPP3 in BG was highly specific showing a close resemblance
to the distribution of the neurotransmiter transporter Glast, which is involved in fast
glutamate removal during synaptic events (Takayasu et al. 2009). This suggested the
participation of LPP3 in some aspects of neuron-glia communication through the
dephosphorylation of extracellular bioactive lipids such as S1P and LPA. Since these lipids
lead to a variety of effects in neurons and astrocytes we designed strategies to conditionally
inactivate LPP3 gene function in neuroglial lineages.
We demosntrated that lack of LPP3 protein/activity in BG produces an increase in the
concentration of S1P and the down-regulation of S1P1 in adult and developing cerebellum,
indicating that LPP3 in BG contributes to the regulation of S1P metabolism and signaling in
this structure in vivo. These data, in addition to the expression of S1P synthesizing enzymes
in the cerebellum, as well as the described effects of S1P in some cerebellar cell types,
suggested that the tight regulation of S1P metabolism/signaling might be relevant for some
aspects of cerebellum development and/or physiology.
In this work we characterized the cerebellar alterations produced by the lack of LPP3
expression in the nervous system: 1) appearance of an abnormal lingular-like sulcus with
ectopic neurons, in the most rostral domain of the vermis; 2) hypoplasia of folias and
reduction or disappearance of fissurae/sulci and 3) abnormal morphology and arrangement
of BG cells. Most of these abnormalities have a developmental origin and could be
attributed to changes in cell morphology and/or density of LPP3-positive radial glia as will
be discussed immediately after.
In the case of the sulcus with ectopic cells, abnormal development of the velum medullaris
can afford for this phenotype. It has been suggested that this structure arises from active
proliferation of cells in the VZ and the posterior retraction of the anterior end of the vermis
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causing the velum to delaminate from the anterior cerebellum and expand (Louvi et al.
2003). Based on the expression pattern of LPP3 and the phenotypic analysis of CKO, we
propose that in the perinatal cerebella, LPP3-expressing cells in the velum and in the
junction between the velum and the anterobasal lobe of the vermis (Fig. 2) play a
fundamental role in controlling the elongation of the velum and proper formation of the glia
limitans in this area. In the absence of LPP3, abnormal “contraction/tension” of cells in the
velum area folds the anterior end of the vermis and drag some cells, accounting for ectopic
neurons found in this area. Alternatively, cells might move farther as a consequence of the
loss of a restrictive signal at the MHB imposed by LPP3 or the phenotype might be the
consequence of a mild midline fusion defect, but these possibilities have to be tested.
LPP3 deficiency modifies cerebellum foliation in part through alterations in EGC
proliferation in a regional and temporal fashion. It is established that proliferation kinetics of
EGC is controlled by SHH produced from PC and modulated by several factors (Vaillant
and Monard 2009). Our evidence shows that LPP3 is not obviously expressed in PC or EGC,
thus the alteration on EGC proliferation in the CKO should be an indirect consequence of
the absence of LPP3 in BG cells. One possibility is that the decrease in BG cell-density
affects one of the components that positively regulate SHH signaling in the EGC. This
notion is supported by the regional decrease in BG proliferation observed during CKO
cerebellum development, which correlates with areas showing a broader decrease in EGC
proliferation (i.e. at P4). A close correlation in the spatial-temporal patterns of proliferative
activity between these cell types has been also suggested for the rat (Shiga et al. 1983). The
possibility that foliation defects are a consequence of the general reduction in size of CKO
animals is unlikely, as the change in size does not seem to be a critical factor in determining
the pattern of cerebellar foliation (Millen et al. 1994)
LPP3-deficiency in BG cells reduces their proliferation partly accounting for the decrease in
BG density in later stages. Since S1P released by cerebellar astrocytes induces its
proliferation (Bassi et al. 2006), it is possible that the accumulation of extracellular S1P
caused by the absence of LPP3, induces the desensitization/degradation of S1P receptors
that mediate BG proliferation. In support of this notion is the early down-modulation of
S1P1 found in the CKO cerebellum from P4, which correlates with the stage in which more
effects on BG proliferation were found (Figs. 7, S2).
A great body of evidence supports that alterations in the cytoarchitectonic features of BG
cells may produce alterations in EGC migration due to abnormal scaffold formation (Eiraku
et al. 2005; Lin et al. 2009; Qu and Smith 2005; Rakic and Sidman 1973; Weller et al.
2006). In our LPP3 CKO cerebella, EGC migration is delayed without affecting their
differentiation since expression of p27 in the inner EGL is normal. However, cell death of
differentiated GC trapped in the EGL and ML was suggested by the increase in TUNEL
positive cells found in these areas in CKO cerebella at P15. Thus, foliation defects found in
LPP3 deficient cerebella arise from a combination of events, namely, reduction in the
amount of EGC due to reduced proliferation, a delay in EGC migration and a late increase in
GC death.
Posterior to the migration of BG somas from the ventricular zone through the cerebellar
medulla, they arrange in an epithelium-like lining in the PCL. Lack of LPP3 also produces
alterations in the arrangement of BG into this layer. This phenotype, aside from changes in
the BG cytoarchitecture and delayed EGC migration, has been associated to disrupted
activation of the Notch signaling, a pathway involved in intercellular interaction (Eiraku et
al. 2005; Komine et al. 2007; Weller et al. 2006). Whether the absence of LPP3 is affecting
the interactions between PC and BG through the alteration of the Notch signaling or other
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mechanism regulating intercellular interaction is an intriguing idea that remains to be
analyzed.
As previously highlighted, the broad phenotypic alterations found in the LPP3 CKO
cerebellum seemed mainly associated to alterations in the cytoarchitectonic features of BG.
S1P-mediated signaling regulates cell adhesion and/or cell shape in glial cells
(Mullershausen et al. 2007; Tas and Koschel 1998) and cerebellar astrocytic proliferation in
vitro (Bassi et al. 2006). Since LPP3 and S1P1 are extremely abundant in BG (this work and
Nishimura et al. 2010), and that lack of LPP3 increases the availability of S1P and down-
regulates S1P1 in BG, it was possible that most of the abnormalities found in this cell type
originated from altered S1P/S1P1 metabolism/signaling. The similar changes in cell
morphology and alterations in soma arrangement found in BG, in addition to the significant
reduction in the expression of S1P1 in our in vitro and in vivo pharmacological treatments
with the S1P receptor modulator FTY720, strongly supports this hypothesis. The phenotypic
rescue with the conditional expression in BG of a mutant version of S1P1 that cannot be
internalized in our Nes-Cre;Ppap2bFloxed background, or the phenocopy of the phenotypes
with the conditional ablation of S1P1 in this particular cell type will ultimately clarify this
issue.
Lack of LPP3 in the nervous system also produces a mild motor coordination defect.
Establishing whether structural or electrophysiological abnormalities in the cerebellum are
responsible for this motor dysfunction will require further investigation. However, it is
suggestive that the anterior lobule of the cerebellum, the region that primordially controls
the movement of posterior appendages (Manni and Petrosini 2004), is the most altered in our
mice. Alternatively, modifications in lysophospholipid signaling due to the absence of LPP3
could originate electrophysiological alterations that compromise information processing of
the cerebellum. For instance, altered S1P-mediated signaling might affect glutamatergic
neurotransmission (Sim-Selley et al. 2009). Our neural specific LPP3 knockout constitutes a
suitable model to analyze the role of LPP3 and lysophospholipids in BG cell function and
cerebellar physiology in general.
Finally, the tight functional connection between LPP3 and the regulation of S1P1 expression
at the plasma membrane is highly significant since the down-regulation of this receptor is
the mechanism by which the immunomodulator FTY720 works in the treatment of some
autoimmune diseases (Brinkmann 2009; Nixon 2009). In this sense, it will be interesting to
explore if regulating the expression or activity of LPP3 could also contribute to the
treatment of this kind of diseases.
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Figure 1. Expression of LPP3 in the adult brain and Bergmann glia
(A–B) β-galactosidase staining (blue) of a Ppap2b+/lacZ reporter mouse brain. Confocal
images of triple (C–H) or double (I–Q) immunofluorescence in the molecular layer of WT
cerebellum, using Abs against the indicated proteins. LPP3 is not expressed in parvalbumin-
positive PC (H, O–Q) and S100B-positive radial processes of BG (L–N), but co-localize
with Glast-expressing plasma membrane domains (H–K) and S100B-positive lateral braches
of BG cells (yellow in N and arrowheads). Few LPP3-positive radial processes were
observed near the pial surface (P). Note the close apposition of LPP3-expressing processes
to PC dendrites (Q, arrowheads). BGs, Bergmann glia somas; Cb, cerebellum; Ctx, cortex;
dt, dendritic tree; gc, granule cells; hy, hypothalamus; IC, inferior coliculus; in,
interneurons; iv, fourth ventricle; ML, molecular layer; ob, olfactory bulb; Parv,
Parvalbumin; PC, Purkinje cell; PCL, Purkinje cell layer; rms, rostral migratory stream; rp,
radial processes; vs, ventricular system; Capitalized roman numbers identify the folias of the
cerebellum at the level of the vermis; Scale bars: B, 0.5 mm; C, E, G, 30 µm; D, F, H; 20
µm; H inset, 2 µm.; I, 5 µm; L, 10 µm; O–Q, 5 µm.
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Figure 2. Developmental expression of LPP3 in the cerebellum
Cerebella, at the stages indicated, were stained for β-gal (blue in A and inset in D), for LPP3
by immunohistochemistry (purple; B, D) and immunofluorescence (green, C, E–F) and for
Parvalbumin (red, E, F). Asterisks in A show Ppap2blacZ expression domains. White
arrowheads in B and C show expression in anterior cerebellum and VM, and black arrows
show expression in the developing PCL. Asterisk in C indicates the developing central lobe.
Arrows in D and arrowheads in F indicate LPP3-positive radial processes. AB, anterobasal
lobe; CP, cerebellum primordium; EGL, external granule layer; iv, fouth ventricle; MB,
midbrain; mg, meninges; VM, velum medullaris; Scale bars: A–C and inset in D, 100 µm;
D, F, 20 µm; E, 30 µm.
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Figure 3. Neural deficiency of LPP3 produces alterations in S1P metabolism and down-
regulation of S1P1
A) Western blot and immunofluorescence analyses of LPP3 in total protein extracts of
cerebella from f/f, Δf/+ or Δf/Δf mice. (B) Mass spectrometric analysis of total S1P species
extracted from control and CKO cerebella. Mean ± SD (n=3), t test *(p<0.05). (C) S1P1/
Glast double immunofluorescence in sagittal sections at the level of the vermis, from P16
control and CKO cerebellum. (D) Western blot analysis of S1P1 at the stages indicated. igl,
internal granule layer; ML, molecular layer. Scale bar: 50 µm.
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Figure 4. Motor coordination defects in animals lacking neural expression of LPP3
(A) Latency to fall in seconds (sec) on the Rotarod test in control (f/f;Δf/+) and CKO (Δf/
Δf) animals. Mean ± sem, t test *(p<0.05). (B) Locomotion pattern of mice on the fixed bar
(5 mm diameter).
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Figure 5. Foliation and BG cytoarchitectonic defects in the LPP3 deficient cerebellum
Histological (A, E) and immunofluorescence (B–D, F–H) analyses in sagittal sections at the
mid vermis. Parvalbumin was used to identify Purkinje cells and interneurons (B, F) while
GFAP and BLBP were used to identify radial processes or somas and radial processes in BG
respectively (C, G; D, H). (I) Quantitative analysis of different cell types densities in the
Purkinje cell and molecular layers. Mean ± sem, n=#slices(#animals), t test ***(p<0.001).
Asterisk in A and E indicates the folia IV–V. Rectangle in E shows abnormal lingular-like
sulcus. Non-specific fluorescence signal in C, G appears in yellow. Arrow in G show
abnormal BG morphology. Arrowheads in H indicate ectopic BG. icf, intercrural fissure; in,
interneuron; ML, molecular layer; p, pia; pcf, precentral fissure; PCL, Purkinje cell layer;
us, uvular sulcus. Scale bars: A, E, 0.5 mm; B–D, F–H, 50 µm.
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Figure 6. The LPP3-deficient cerebellum shows early alterations in BG cytoarchitecture and
arrangement
Sagittal sections from control (A, C) and CKO (B, D) cerebellum at the level of the vermis,
processed for immunofluorescence against BLBP (green) at P4 or P15. Note that in P4
mutant sections, BG somas are not as homogeneously arranged below Purkinje cells and
appear less abundant; at P15, BG somas are abnormally found in the ML (arrowheads in D).
Square brackets in C and D indicate the thickness of EGL. IGL, internal granule layer; *,
Purkinje cells. Scale bar: 30 µm.
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Figure 7. Developing LPP3-deficient cerebella show alterations in EGC migration, proliferation
and cell death
Sagittal sections at the level of the vermis from Ppap2bflox/flox and Ppap2bNΔflox/NΔflox
cerebella of the indicated stages processed for: immunoperoxidase against PCNA (A–B) or
p27 (C–D), p-Histone-H3 immunofluorescence (E) or TUNEL (F). Images taken at the
bottom of the primary fissure (A–B) in the area indicated by the arrow (insets) or at the
intercrural fissure (C–D). Square brackets indicate the thickness of the labeled EGL.
Arrowheads in (A) show PCNA-positive cells and in (C–D) migrating GC. (E)
Representative image of p-Histone-H3 staining in cerebella at P4, the area showed
corresponds to folia IV–V (asterisks in insets); note the decrease in proliferation in CKO. (F)
At P15, TUNEL assay showed a considerable rise in cell death in the EGL and ML of CKO,
the area showed corresponds to the secondary fissure area (asterisks in insets). (G–H)
Analysis of p-Histone-H3 (pHH3) and TUNEL-positive cells in the EGL (G) and PCL (H)
at the stages indicated. At least 3 animals/genotype/stage were evaluated, except for P15
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TUNEL (n=2). Values are mean ± sem, t test *(p<0.05) and **(p<0.01). ec, endothelial cell.
Scale bar: A–D, 30 µm; E–F, 50 µm.
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Figure 8. Treatment with FTY720 partially mimics the BG alterations seen in the neural LPP3
CKO cerebellum
BLBP detected in P7 cerebellum organotypic slice cultures from f/f (A) and Δf/Δf (B)
cerebellum; note that morphology of BG is very similar to that found in non-cultured tissue,
including end-feet that do not reach the pial surface (arrows), thickening of radial processes
and reduction of lateral processes complexity. Organotypic culture from wildtype
cerebellum sections treated with vehicle (C) or FTY720 (D); note thickening of BLBP-
positive BG processes (arrows) in those treated with the drug. A slight decrease in lateral
processes complexity is detected. Detection of BLBP (E–F), S1P1 (G–H) or PCNA (I–J) in
P14 cerebellum sections from wildtype animals treated 11 days with vehicle (E, G, I) or
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FTY720 (F, H, J). (E, F) In FTY720-treated animals, thickening of BG processes (arrows in
F), irregular arrangement of BG somas within the PCL and ectopic somas in the ML
(arrowheads and inset in F) were found. (G, H) FTY720 treatment causes a strong, although
not complete, down-regulation of S1P1, since some staining was still observed in the ML
and in some BG shafts (compare the staining labeled by arrows in G and H). (I, J) The
thickness of PCNA-positive (dark purple) intercrural EGL in FTY720 treated animals was
larger than in controls. Arrows in G indicate S1P1-positive BG radial processes. Asterisks in
E–H indicate Purkinje cell somas; p; pial surface. Scale bar: A–H, 20 µm; I–J, 40 µm.
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